Longer-term Efficacy of Ofatumumab in Patients with Relapsing Multiple Sclerosis

被引：0

作者：

Kappos, L. ^{[1
,2
,3
]}

Fox, E. ^{[4
]}

Aungst, A. ^{[5
]}

Su, W. ^{[6
]}

Zielman, R. ^{[7
]}

Gupta, A. ^{[8
]}

Xi, J. ^{[9
]}

Stoneman, D. ^{[10
]}

Robertson, D. ^{[3
,5
]}

Cohen, J. ^{[11
]}

Hauser, S. ^{[12
]}

机构：

[1] Univ Hosp, Res Ctr Clin Neuroimmunol & Neurosci Basel, Basel, Switzerland

[2] Univ Hosp, MS Ctr, Dept Head, Clin Res Biomed & Biomed Engn, Basel, Switzerland

[3] Univ Hosp, MS Ctr, Dept Spine & Neuromed, Clin Res Biomed & Biomed Engn, Basel, Switzerland

[4] Univ Texas, Dell Med Sch, Cent Texas Neurol Consultants, Round Rock, TX USA

[5] Univ S Florida, Multiple Sclerosis Div, Dept Neurol, Tampa, FL USA

[6] Novartis Pharmaceut, E Hanover, NJ USA

[7] Novartis Pharma BV, Amsterdam, Netherlands

[8] Novartis Healthcare Pvt Ltd, Hyderabad, Telangana, India

[9] China Novartis Inst Biomed Res Co Ltd, Shanghai, Peoples R China

[10] Novartis Pharma AG, Basel, Switzerland

[11] Cleveland Clin, Neurol Inst, Dept Neurol, Mellen MS Ctr, Cleveland, OH USA

[12] Univ Calif San Francisco, UCSF Weill Inst Neurosci, San Francisco, CA 94143 USA

来源：

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

EPR-161

引用

页码：284 / 285

页数：2